Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision number updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:42:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the previous funding/operating status notice (Revision: v3.4.1) has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T12:14:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operating status was added. The site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:36:19.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI text updates were applied, adding 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:26:46.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 in place of Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T03:08:05.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Locations section now lists Michigan and Ohio as study sites and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and the previous Michigan/Ohio Locations entries were removed.
    Difference
    0.4%
    Check dated 2025-12-23T13:32:37.000Z thumbnail image

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.